Preprint Article Version 1 Preserved in Portico This version is not peer-reviewed

Do Human iPSC Derived Cardiomyocytes Cultured on PLA Scaffolds Induce Expression of CD28/CTLA 4 by T Lymphocytes?

Version 1 : Received: 24 December 2021 / Approved: 28 December 2021 / Online: 28 December 2021 (17:37:34 CET)

A peer-reviewed article of this Preprint also exists.

Sergeevichev, D.; Balashov, V.; Kozyreva, V.; Pavlova, S.; Vasiliyeva, M.; Romanov, A.; Chepeleva, E. Do Human iPSC-Derived Cardiomyocytes Cultured on PLA Scaffolds Induce Expression of CD28/CTLA-4 by T Lymphocytes? J. Funct. Biomater. 2022, 13, 6. Sergeevichev, D.; Balashov, V.; Kozyreva, V.; Pavlova, S.; Vasiliyeva, M.; Romanov, A.; Chepeleva, E. Do Human iPSC-Derived Cardiomyocytes Cultured on PLA Scaffolds Induce Expression of CD28/CTLA-4 by T Lymphocytes? J. Funct. Biomater. 2022, 13, 6.

Journal reference: J. Funct. Biomater. 2022, 13, 6
DOI: 10.3390/jfb13010006

Abstract

Different types of engineered cardiac constructs are being developed nowadays by many research groups. However, the immunological properties of such artificial tissues are not yet clearly understood. Previously, we have studied microfiber scaffolds carrying iPSC-derived cardiomyocytes. In this work, we evaluated the ability of these tissue-engineered constructs to activate the expression of CD28 and CTLA-4 proteins in T-lymphocytes which are early markers of the immune response. For this purpose electrospun PLA nanofibrous scaffolds were seeded with human iPSCs-CM and cultivated for 2 weeks. After, allogeneic mononuclear cells were co-cultured during 48 hours with 3 groups of samples that were tissue-engineered constructs, pure culture of cardiomyocytes and bare scaffolds followed by analysis of CD28/CTLA-4 expression on T-lymphocytes via flow cytometry. PLA scaffolds and concanavalin A (positive control) stimulation statistically significantly increased CD28 expression on CD4+ cells (up to 61.3% and 66.3%) and on CD8+ cells (up to 17.8% and 21.7%). CD28/CTLA-4 expression didn’t increase during co-cultivation of T-lymphocytes with cardiac engineered constructs and iPSC-CM monolayers. Thus, iPSCs-CM in monolayers and on PLA nanofibrous scaffolds didn’t cause T-cell activation, which allows us to expect that such cardiac constructs are not a cause of rejection after implantation.

Keywords

graft rejection; iPSC; differentiation; cardiomyocytes; electrospinning; CD28; CTLA-4; immune response

Subject

LIFE SCIENCES, Other

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our diversity statement.

Leave a public comment
Send a private comment to the author(s)
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.

We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.